Nanoray-1100: A Phase I Study Of Nbtxr3 Activated By Radiotherapy In Patients With Advanced Cancers Treated With Anti-Pd-1 Therapy

Colette J. Shen,Katherine LaRoque Jameson,Jared Weiss,Trevor Hackman,Robert Dixon,Jason A. Akulian,Alexander T. Pearson,Jessica Frakes,Patricia Said,Tanguy Y. Seiwert

JOURNAL OF CLINICAL ONCOLOGY（2020）

Cited 2|Views61

No score

Abstract

TPS86Background: Most cancer patients present resistance to immune therapy; only approximately 15% of patients respond to immune checkpoint inhibitors (ICI). Strategies able to increase ICI respons...

Translated text

Key words

nbtxr3,radiotherapy,advanced cancers

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined